Cost-Saving Technology that Drastically Reduces Readmittance Rates of Chronically Ill Patients.

Trusted by Leading Insurance and Healthcare Organizations

Technology and Advocacy to Improve Patient Adherence Rates and Connect Physicians and Their Patients

Patients who fail to take their medications as prescribed face an increased chance of disease progression, extended hospital stays or even death. In addition to the personal consequences of poor adherence, morbidity and mortality costs are estimated at over $528 billion annually.

IV Ensure is designed to address these issues head on. Our model pushes adherence rates to 90%, while providing physicians insights into their patients’ care received at home. Our patented technology combined with data analytics and our team of experienced care managers supports patients throughout their infusion journey. We understand there may be obstacles patients face when infusing at home, and our care managers are trained to support patients and overcome those obstacles.

IV Ensure connects physicians and their patients to promote higher adherence rates leading to better health outcomes and reduced overall healthcare costs. IV Ensure supports home-infusion patients throughout their infusion journey and provides valuable insights to the physician allowing them to make better informed decisions about the care their patients receive at home.

Historically, it is challenging to objectively measure adherence rates due to the high costs and intrusiveness of available methods. IV Ensure delivers an accurate picture of a given patient’s adherence rates in a cost-effective and non-invasive manner, and our care managers support those patients who might otherwise struggle to take their infusion medication as prescribed.

Studies show that health outcomes improve, and costs go down when patients adhere to the medication therapies prescribed by their doctors. Simply adhering to the prescribed therapy can have a greater impact on outcomes than the specific treatment itself. Many patients stop taking their medications, often without discussing it with their physician, within a few days, weeks, or months. Some patients never even start.

Medication adherence is the complex interplay between motivation and ability, and successful adherence is generally defined as patients taking their medication as prescribed at least 80% of the time. IV Ensure’s model pushes adherence rates to over 90% by providing support to the patient throughout their infusion journey. Feedback from our infusion patients is overwhelmingly positive, and they appreciate the support IV Ensure provides.

Mitchell Berenson, our founder, has an entrepreneurial spirit and a passion for helping people. Educated at Oklahoma State University, the Oklahoma University Health Science Center, and Johns Hopkins. He co-founded Community Infusion Solutions in 2008 to make hospital-based infusion therapy more accessible to rural communities, and the company has successfully managed over 26,000 patients in 14 states.

Even before the COVID 19 pandemic accelerated growth in the home infusion market, Mitchell and Debbie Meyer started working on the first iteration of the device that would become IV Ensure. Our goal from the beginning was to empower patients to improve their adherence rates, and simultaneously provide valuable insights to physicians regarding the care their patients receive while at home. As the home infusion market continues to grow, remote therapeutic monitoring promoting adherence rates will become even more important to patients individually and society at large.